These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1983184)

  • 21. Nucleosides. 146. 1-Methyl-5-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil, the C-nucleoside isostere of the potent antiviral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)thymine (FMAU). Studies directed toward the synthesis of 2'-deoxy-2'-substituted arabino nucleosides. 6.
    Pankiewicz KW; Nawrot B; Gadler H; Price RW; Watanabe KA
    J Med Chem; 1987 Dec; 30(12):2314-6. PubMed ID: 2824777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine.
    Colacino J; Brownridge E; Greenberg N; Lopez C
    Antimicrob Agents Chemother; 1986 May; 29(5):877-82. PubMed ID: 3015008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
    Schinazi RF; Peters J; Sokol MK; Nahmias AJ
    Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
    Cheng YC; Dutschman G; Fox JJ; Watanabe KA; Machida H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):420-3. PubMed ID: 6272634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus.
    Schat KA; Schinazi RF; Calnek BW
    Antiviral Res; 1984 Oct; 4(5):259-70. PubMed ID: 6097179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.
    Borthwick AD; Evans DN; Kirk BE; Biggadike K; Exall AM; Youds P; Roberts SM; Knight DJ; Coates JA
    J Med Chem; 1990 Jan; 33(1):179-86. PubMed ID: 2153201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
    Mayo DR; Hsiung GD
    Antimicrob Agents Chemother; 1984 Sep; 26(3):354-7. PubMed ID: 6239591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
    Wang J; Eriksson S
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1555-7. PubMed ID: 8726039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.
    Fourel I; Li J; Hantz O; Jacquet C; Fox JJ; Trépo C
    J Med Virol; 1992 Jun; 37(2):122-6. PubMed ID: 1629711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
    Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
    J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
    Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
    J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in the recognition of nucleoside analogues as substrates by the deoxythymidine kinase of a 5-methoxymethyldeoxyuridine-resistant mutant of herpes simplex virus type 1.
    Veerisetty V; Veerisetty IK; Gentry GA
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2767-70. PubMed ID: 6319559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
    Feinberg A; Leyland-Jones B; Fanucchi MP; Hancock C; Fox JJ; Watanabe KA; Vidal PM; Williams L; Young CW; Philips FS
    Antimicrob Agents Chemother; 1985 May; 27(5):733-8. PubMed ID: 2990323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
    Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
    Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro.
    Osterhaus AD; Groen J; De Clercq E
    Antiviral Res; 1987 May; 7(4):221-6. PubMed ID: 3619434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.